HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

10th Edition of International Conference on
Dentistry and Oral Health

March 13-15, 2025 | Rome, Italy
Dental 2023

Dalia Ghalwash

Dalia Ghalwash, Speaker at Dentistry Conference
The British University in Egypt, Egypt
Title : Advances of salivary biomarkers in oral cancer and pre cancer detection


Statement of the Problem: Oral cancer is considered the sixth most common cancer across the world, creating a significant global health burden. Despite the progress in preventive and therapeutic strategies, delay in oral cancer diagnosis remains a major cause of high morbidity and mortality. On the other hand, the survival rate increases up to 80% if an early diagnosis is achieved. Salivary biomarkers constitute major progress in the diagnosis of oral cancer and are a rapidly developing arena of scientific research, it is also considered a promising prognostic and diagnostic tool in oral malignant and oral premalignant conditions. The purpose of this study is to report the most recent data on the diagnostic and prognostic value of salivary biomarkers in oral cancer and precancer.
Methodology: A literature search was performed using the Cochrane Library and PubMed databases from 1995 till the present.
Results: In the recent biological era “omics” method is a new biomarker detection tool that emphasizes exploring many molecules present in saliva. Presently, five main salivary diagnostic constituents are recognized; genomics, transcriptomics, proteomics, metabolomics, and microbiomics. Recent systematic reviews with high value of evidence have shown that salivary biomarkers analysis can be an excellent primary screening tool for high-risk cases of oral cancer and that combining these biomarkers with conventional tools could provide more potent diagnostic values for early detection of oral precancer and cancer.
Conclusion & Significance: A combination of multiple biomarker candidates in prompt detection of oral precancer and cancer is preferred to improve accuracy, sensitivity, and reliability. This can bring salivaomics to clinical point-of-care applications. Clinical relevance: The use of salivary biomarkers is beneficial in the screening of high-risk cases and is available for practitioners to apply to their clinical practice.


Professor Dalia Ghalwash has expertise in the field of Oral Medicine, Diagnosis, and Periodontology with a special interest in the diagnosis and early detection of oral cancer and precancer. She has a passion for improving oral health and trying to reduce the mortality rate of oral cancer. She has years of experience in scientific research with many national and international publications in her field, in addition to a long teaching experience in huge educational institutions. She is currently the Head of the Oral Medicine, Diagnosis, and Periodontology Department and the Chair of the Research Ethics Committee of the Faculty of Dentistry, The British University in Egypt.